Entrectinib as a Single Agent in Upfront Therapy for Children <3 Years of Age With NTRK1/2/3 or ROS1-FUSED CNS Tumors
St. Jude Children's Research Hospital
St. Jude Children's Research Hospital
Columbia University
St. Jude Children's Research Hospital
Masonic Cancer Center, University of Minnesota
OHSU Knight Cancer Institute
Eastern Cooperative Oncology Group
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Children's Oncology Group
Children's Hospital of Philadelphia
Children's Oncology Group
Societe Internationale d'Oncologie Pediatrique
Children's Oncology Group
Masonic Cancer Center, University of Minnesota
Dana-Farber Cancer Institute
City of Hope Medical Center
Dana-Farber Cancer Institute
Alliance for Clinical Trials in Oncology
Alliance for Clinical Trials in Oncology
Dana-Farber Cancer Institute
NYU Langone Health
Children's Oncology Group
Dana-Farber Cancer Institute
Children's Oncology Group
Children's Oncology Group
Children's Oncology Group
Children's Oncology Group
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Mayo Clinic
Mayo Clinic
Roswell Park Cancer Institute